Human cytochrome P450 4F3: Structure, functions, and prospects

Drug Metabolism and Drug Interactions

Volumn 27, Issue 2, 2012, Pages 63-71

  Corcos, Laurent ^a   Le Lucas, Daniè ^a   Le Jossic Corcos, Catherine ^a   Dréano, Yvonne ^a   Simon, Brigitte ^a   Plée Gautier, Emmanuelle ^a   Amet, Yolande ^a   Salaüna, Jean Pierre ^a  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

BYP4F3B; CYP4F3A; Gene regulation; Lipid metabolism

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,5 BIS(4 AMIDINOPHENYL)FURAN; 3,18 DIHYDROXYSTEARATE; AMITRIPTYLINE; ARACHIDONIC ACID; BENZPHETAMINE; BETA NAPHTHOFLAVONE; CYTOCHROME P450; CYTOCHROME P450 4F3; DAPSONE; DEXAMETHASONE; DOCOSAHEXAENOIC ACID; EBASTINE; ERYTHROMYCIN; FINGOLIMOD; ICOSAPENTAENOIC ACID; IMIPRAMINE; LIPOXIN A; LIPOXIN B; MICONAZOLE; PAFURAMIDINE; PALMITIC ACID; PARAFURAMIDINE; PHENOBARBITAL; PIRENZEPINE; RETINOIC ACID; RIFAMPICIN; STEARIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOBIOTIC AGENT; CYP4F3 PROTEIN, HUMAN; FATTY ACID; MESSENGER RNA;

AMINO ACID SEQUENCE; CELL DEATH; CHEMICAL STRUCTURE; CONFERENCE PAPER; DRUG METABOLISM; FATTY ACID METABOLISM; GENE CONTROL; GENE FUNCTION; GENE STRUCTURE; HUMAN; LIPID METABOLISM; NONHUMAN; PHYLOGENETIC TREE; RNA SPLICING; XENOBIOTIC METABOLISM; ALTERNATIVE RNA SPLICING; ANIMAL; BIOSYNTHESIS; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; FATTY ACIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIPID METABOLISM; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; XENOBIOTICS;

EID: 84867283399     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI-2011-0037     Document Type: Conference Paper

References (53)

1. Hardwick JP. Cytochrome P450hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol 2008;75:2263-75.
2. Nelson DR. Cytochrome P450 nomenclature, 2004. Methods Mol Biol 2006;320:1-10.
3. Kikuta Y, Kusunose E, Kusunose M. Cloning and expression of a novel form of leukotriene B4-hydroxylase from human liver. FEBS Lett 1994;348:70-4. (Pubitemid 24223036)
4. Bylund J, Finnstrom N, Oliw EH. Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles. Biochem Biophys Res Commun 1999;261:169-74. (Pubitemid 29371636)
5. Le Quere V, Plee-Gautier E, Potin P, Madec S, Salaun JP. Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. J Lipid Res 2004;45:1446-58. (Pubitemid 39006972)
6. Cui X, Nelson DR, Strobel HW. A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning, expression, and genomic structural characterization. Genomics 2000;68:161-6.
7. Kalsotra A, Turman CM, Kikuta Y, Strobel HW. Expression and characterization of human cytochrome P450 4F11: putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol Appl Pharmacol 2004;199:295-304. (Pubitemid 39208729)
8. Bylund J, Bylund M, Oliw EH. cDna cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem Biophys Res Commun 2001;280:892-7. (Pubitemid 32924516)
9. Hashizume T, Imaoka S, Hiroi T, Terauchi Y, Fujii T, Miyazaki H, et al. cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine. Biochem Biophys Res Commun 2001;280:1135-41. (Pubitemid 32924458)
10. Stark K, Schauer L, Sahlen GE, Ronquist G, Oliw EH. Expression of CYP4F12 in gastrointestinal and urogenital epithelia. Basic Clin Pharmacol Toxicol 2004;94:177-83. (Pubitemid 38525314)
11. Lefevre C, Bouadjar B, Ferrand V, Tadini G, Megarbane A, Lathrop M, et al. Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum Mol Genet 2006;15:767-76. (Pubitemid 43264701)
12. Nilsson T, Ivanov IV, Oliw EH. LC-MS/MS analysis of epoxyalcohols and epoxides of arachidonic acid and their oxygenation by recombinant CYP4F8 and CYP4F22. Arch Biochem Biophys 2010;494:64-71.
13. Kirischian NL, Wilson JY. Phylogenetic and functional analyses of the cytochrome P450 family 4. Mol Phylogenet Evol 2012;62: 458-71.
14. Sontag TJ, Parker RS. Cytochrome P450-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 2002;277:25290-6. (Pubitemid 34951838)
15. Sanders RJ, Ofman R, Dacremont G, Wanders RJ, Kemp S. Characterization of the human-oxidation pathway for-hydroxy-very-long-chain fatty acids. FASEB J 2008;22:2064-71. (Pubitemid 351811482)
16. Wang MZ, Saulter JY, Usuki E, Cheung YL, Hall M, Bridges AS, et al. CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl) furan-bis-Omethylamidoxime]. Drug Metab Dispos 2006;34:1985-94. (Pubitemid 44837759)
17. Wang MZ, Wu JQ, Bridges AS, Zeldin DC, Kornbluth S, Tidwell RR, et al. Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine. Drug Metab Dispos 2007;35:2067-75. (Pubitemid 350005197)
18. Kikuta Y, Kusunose E, Endo K, Yamamoto S, Sogawa K, Fujii- Kuriyama Y, et al. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4-hydroxylase. J Biol Chem 1993;268:9376-80. (Pubitemid 23145985)
19. Christmas P, Ursino SR, Fox JW, Soberman RJ. Expression of the CYP4F3 gene. Tissue-specifi c splicing and alternative promoters generate high and low K(m) forms of leukotriene B(4) -hydroxylase. J Biol Chem 1999;274:21191-9.
20. Christmas P, Jones JP, Patten CJ, Rock DA, Zheng Y, Cheng SM, et al. Alternative splicing determines the function of CYP4F3 by switching substrate specifi city. J Biol Chem 2001;276:38166-72.
21. Logette E, Wotawa A, Solier S, Desoche L, Solary E, Corcos L. The human caspase-2 gene: alternative promoters, premRNA splicing and AUG usage direct isoform-specifi c expression. Oncogene 2003;22:935-46. (Pubitemid 36255829)
22. Christmas P, Carlesso N, Shang H, Cheng SM, Weber BM, Preffer FI, et al. Myeloid expression of cytochrome P450 4F3 is determined by a lineage-specifi c alternative promoter. J Biol Chem 2003;278:25133-42. (Pubitemid 37548677)
23. Zhang Q, Piston DW, Goodman RH. Regulation of corepressor function by nuclear NADH. Science 2002;295:1895-7. (Pubitemid 34214127)
24. Kalsotra A, Du L, Wang Y, Ladd PA, Kikuta Y, Duvic M, et al. Infl ammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways. FASEB J 2008;22:538-47. (Pubitemid 351225590)
25. Dhar M, Sepkovic DW, Hirani V, Magnusson RP, Lasker JM. Oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. J Lipid Res 2008;49: 612-24.
26. Costa CG, Dorland L, Holwerda U, de Almeida IT, Poll-The BT, Jakobs C, et al. Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid -oxidation disorders. Clin Chem 1998;44:463-71. (Pubitemid 28141339)
27. Dorland L, Ketting D, Bruinvis L, Duran M. Medium- and longchain 3-hydroxymonocarboxylic acids: analysis by gas chromatography combined with mass spectrometry. Biomed Chromatogr 1991;5:161-4.
28. Kikuta Y, Kusunose E, Kusunose M. Prostaglandin and leukotriene -hydroxylases. Prostaglandins Other Lipid Mediat 2002;68-69:345-62.
29. Goh J, Godson C, Brady HR, Macmathuna P. Lipoxins: pro-resolution lipid mediators in intestinal infl ammation. Gastroenterology 2003;124:1043-54. (Pubitemid 36389807)
30. Hersberger M. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins. Clin Chem Lab Med 2010;48:1063-73.
31. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000;105:1067-75. (Pubitemid 30217691)
32. Fer M, Corcos L, Dreano Y, Plee-Gautier E, Salaun JP, Berthou F, et al. Cytochromes P450 from family 4 are the main hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism. J Lipid Res 2008;49:2379-89.
33. Fer M, Dreano Y, Lucas D, Corcos L, Salaun JP, Berthou F, et al. Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch Biochem Biophys 2008;471:116-25.
34. Antoun J, Goulitquer S, Amet Y, Dreano Y, Salaun JP, Corcos L, et al. CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis. J Lipid Res 2008;49:2135-41.
35. Straus DS, Glass CK. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 2001;21:185-210. (Pubitemid 32303994)
36. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002;82:131-85. (Pubitemid 34654217)
37. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR, et al. 20-Hydroxyeicosatetraenoic acid mediates calcium/ calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 1998;95:12701-6. (Pubitemid 28483828)
38. Miyata N, Seki T, Tanaka Y, Omura T, Taniguchi K, Doi M, et al. Benefi cial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl- N -hydroxyimido formamide], on hemorrhagic and ischemic stroke. J Pharmacol Exp Ther 2005;314:77-85. (Pubitemid 41058243)
39. Medhora M, Dhanasekaran A, Gruenloh SK, Dunn LK, Gabrilovich M, Falck JR, et al. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450- derived products of arachidonic acid and other eicosanoids. Prostaglandins Other Lipid Mediat 2007;82:19-29. (Pubitemid 44880173)
40. Madec S, Cerec V, Plee-Gautier E, Antoun J, Glaise D, Salaun JP, et al. CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload. Drug Metab Dispos 2011;39:1987-96.
41. Jin Y, Zollinger M, Borell H, Zimmerlin A, Patten CJ. CYP4F enzymes are responsible for the elimination of fi ngolimod (FTY720), a novel treatment of relapsing multiple sclerosis. Drug Metab Dispos 2010;39:191-8.
42. Veeriah S, Miene C, Habermann N, Hofmann T, Klenow S, Sauer J, et al. Apple polyphenols modulate expression of selected genes related to toxicological defence and stress response in human colon adenoma cells. Int J Cancer 2008;122:2647-55. (Pubitemid 351631365)
43. Calaf GM, Roy D. Human drug metabolism genes in parathion- and estrogen-treated breast cells. Int J Mol Med 2007;20:875-81.
44. Zhao Z, He X, Bi Y, Xia Y, Tao N, Li L, et al. Induction of CYP4F3 by benzene metabolites in human white blood cells in vivo in human promyelocytic leukemic cell lines and ex vivo in human blood neutrophils. Drug Metab Dispos 2009;37:282-91.
45. Bi Y, Li Y, Kong M, Xiao X, Zhao Z, He X, et al. Gene expression in benzene-exposed workers by microarray analysis of peripheral mononuclear blood cells: induction and silencing of CYP4F3A and regulation of DNA-dependent protein kinase catalytic subunit in DNA double strand break repair. Chem Biol Interact 2010;184:207-11.
46. Corcos L, Lagadic-Gossmann D. Gene induction by phenobarbital: an update on an old question that receives key novel answers. Pharmacol Toxicol 2001;89:113-22. (Pubitemid 32905240)
47. Lambert CB, Spire C, Claude N, Guillouzo A. Dose- and timedependent effects of phenobarbital on gene expression profi ling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol 2009;234:345-60.
48. Alexanian A, Rufanova VA, Miller B, Flasch A, Roman RJ, Sorokin A. Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth. Anticancer Res 2009;29:3819-24.
49. Pompeia C, Freitas JJ, Kim JS, Zyngier SB, Curi R. Arachidonic acid cytotoxicity in leukocytes: implications of oxidative stress and eicosanoid synthesis. Biol Cell 2002;94:251-65. (Pubitemid 35363822)
50. Curley CR, Monsuur AJ, Wapenaar MC, Rioux JD, Wijmenga C. A functional candidate screen for coeliac disease genes. Eur J Hum Genet 2006;14:1215-22. (Pubitemid 44642588)
51. Zhu X, Wang Y, Zhang H, Liu X, Chen T, Yang R, et al. Genetic variation of the human -2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection. PLoS One 2011;6:e23730.
52. Costea I, Mack DR, Israel D, Morgan K, Krupoves A, Seidman E, et al. Genes involved in the metabolism of poly-unsaturated fatty-acids (PUFA) and risk for Crohn's disease in children & young adults. PLoS One 2010;5:e15672.
53. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007;102:2016-25. (Pubitemid 47301536)